In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
Abstract Clostridioides difficile infections (CDIs) are an urgent public health threat worldwide and are a leading cause of morbidity and mortality in healthcare settings. The increasing incidence and severity of infections combined with the scarcity of effective anti-CDI agents has made treatment o...
Guardado en:
Autores principales: | Nader S. Abutaleb, Mohamed N. Seleem |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0da84e67d61c438098f83388cd104305 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs
por: Haroon Mohammad, et al.
Publicado: (2021) -
High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
por: Rusha Pal, et al.
Publicado: (2021) -
Faecal transplantation and Clostridioides difficile infection
por: Knežević Darija A., et al.
Publicado: (2021) -
Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
por: Eric R. Littmann, et al.
Publicado: (2021) -
Epidemiology of Clostridioides difficile in South Africa.
por: Pieter de Jager, et al.
Publicado: (2021)